In human patients, the SHP2-D61G variant is known to be associated with higher predisposition to JMML (-like MPN)) and clinical evidence suggests that JMML pathogenesis is related to prenatal stages of blood ontogeny (Behnert et al., 2021). The gene discussed is PTPN11; the disease is myeloproliferative neoplasm.